{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:04:38Z","timestamp":1780333478750,"version":"3.54.1"},"reference-count":75,"publisher":"Federa\u00e7\u00e3o das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,29]]},"DOI":"10.61622\/rbgo\/2026rbgo19","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:32:13Z","timestamp":1780331533000},"source":"Crossref","is-referenced-by-count":0,"title":["Association between exposure to endocrine-disrupting chemicals and polycystic ovary syndrome: a systematic review: a systematic review"],"prefix":"10.61622","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1889-0737","authenticated-orcid":false,"given":"Diemer","family":"Mu\u00f1oz-Verbel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0834-6383","authenticated-orcid":false,"given":"Eutimio","family":"Cueto-Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1843-4782","authenticated-orcid":false,"given":"Albeiro","family":"Marrugo-Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8828-3735","authenticated-orcid":false,"given":"Johana","family":"M\u00e1rquez-L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"47794","reference":[{"key":"key20260601163209_B1","doi-asserted-by":"crossref","first-page":"116154","DOI":"10.1016\/j.envpol.2020.116154","article-title":"Subacute cadmium exposure disrupts the hypothalamic-pituitary-gonadal axis, leading to polycystic ovarian syndrome and premature ovarian failure features in female rats","volume":"269","author":"Costa","year":"2021","unstructured":"1 Costa CS, Oliveira TF, Freitas-Lima LC, Padilha AS, Krause M, Carneiro MT, et al. Subacute cadmium exposure disrupts the hypothalamic-pituitary-gonadal axis, leading to polycystic ovarian syndrome and premature ovarian failure features in female rats. Environ Pollut. 2021;269:116154. doi: 10.1016\/j.envpol.2020.116154","journal-title":"Environ Pollut"},{"issue":"11","key":"key20260601163209_B2","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019444","article-title":"The correlation between UDP-glucuronosyltransferase polymorphisms and environmental endocrine disruptors levels in polycystic ovary syndrome patients","volume":"99","author":"Luo","year":"2020","unstructured":"2 Luo Y, Nie Y, Tang L, Xu CC, Xu L. The correlation between UDP-glucuronosyltransferase polymorphisms and environmental endocrine disruptors levels in polycystic ovary syndrome patients. Medicine (Baltimore). 2020;99(11):e19444. doi: 10.1097\/MD.0000000000019444","journal-title":"Medicine (Baltimore)"},{"key":"key20260601163209_B3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2147\/IJWH.S70314","article-title":"Complications and challenges associated with polycystic ovary syndrome: current perspectives","volume":"7","author":"Palomba","year":"2015","unstructured":"3 Palomba S, Santagni S, Falbo A, La Sala GB. Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Womens Health. 2015;7:745-63. doi: 10.2147\/IJWH.S70314","journal-title":"Int J Womens Health"},{"issue":"4","key":"key20260601163209_B4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","article-title":"The prevalence of polycystic ovary syndrome: a brief systematic review","volume":"13","author":"Deswal","year":"2020","unstructured":"4 Deswal R, Narwal V, Dang A, Pundir C. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci. 2020;13(4):261-71. doi: 10.4103\/jhrs.JHRS_95_18","journal-title":"J Hum Reprod Sci"},{"issue":"1","key":"key20260601163209_B5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ecl.2020.10.002","article-title":"Diagnosis of polycystic ovary syndrome","volume":"50","author":"Chang","year":"2021","unstructured":"5 Chang S, Dunaif A. Diagnosis of polycystic ovary syndrome. Endocrinol Metab Clin North Am. 2021;50(1):11-23. doi: 10.1016\/j.ecl.2020.10.002","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"8","key":"key20260601163209_B6","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls","volume":"3","author":"Witchel","year":"2019","unstructured":"6 Witchel SF, Oberfield SE, Pe\u00f1a AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc. 2019;3(8):1545-73. doi: 10.1210\/js.2019-00078","journal-title":"J Endocr Soc"},{"key":"key20260601163209_B7","article-title":"Characteristics of polycystic ovary syndrome throughout life","volume":"14","author":"Louwers","year":"2020","unstructured":"7 Louwers YV, Laven JS. Characteristics of polycystic ovary syndrome throughout life. Ther Adv Reprod Health. 2020;14:2633494120911038. doi: 10.1177\/2633494120911038","journal-title":"Ther Adv Reprod Health"},{"key":"key20260601163209_B8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bpobgyn.2017.08.008","article-title":"Polycystic ovary syndrome in adolescents","volume":"48","author":"Rothenberg","year":"2018","unstructured":"8 Rothenberg SS, Beverley R, Barnard E, Baradaran-Shoraka M, Sanfilippo JS. Polycystic ovary syndrome in adolescents. Best Pract Res Clin Obstet Gynaecol. 2018;48:103-14. doi: 10.1016\/j.bpobgyn.2017.08.008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"key20260601163209_B9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1515\/hmbci-2014-0003","article-title":"Endocrine disruptors and polycystic ovary syndrome: a focus on Bisphenol A and its potential pathophysiological aspects","volume":"17","author":"Palioura","year":"2014","unstructured":"9 Palioura E, Kandaraki E, Diamanti-Kandarakis E. Endocrine disruptors and polycystic ovary syndrome: a focus on Bisphenol A and its potential pathophysiological aspects. Horm Mol Biol Clin Investig. 2014;17(3):137-44. doi: 10.1515\/hmbci-2014-0003","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"1","key":"key20260601163209_B10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.etap.2015.06.009","article-title":"A review on endocrine disruptors and their possible impacts on human health","volume":"40","author":"Kabir","year":"2015","unstructured":"10 Kabir ER, Rahman MS, Rahman I. A review on endocrine disruptors and their possible impacts on human health. Environ Toxicol Pharmacol. 2015;40(1):241-58. doi: 10.1016\/j.etap.2015.06.009","journal-title":"Environ Toxicol Pharmacol"},{"issue":"9-10","key":"key20260601163209_B11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.crvi.2017.07.004","article-title":"What is an endocrine disruptor?","volume":"340","author":"Monneret","year":"2017","unstructured":"11 Monneret C. What is an endocrine disruptor? C R Biol. 2017;340(9-10):403-5. doi: 10.1016\/j.crvi.2017.07.004","journal-title":"C R Biol"},{"issue":"1","key":"key20260601163209_B12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0036850419826802","article-title":"Endocrine disrupting chemicals: impact on human health, wildlife, and the environment","volume":"102","author":"Encarna\u00e7\u00e3o","year":"2019","unstructured":"12 Encarna\u00e7\u00e3o T, Pais AA, Campos MG, Burrows HD. Endocrine disrupting chemicals: impact on human health, wildlife, and the environment. Sci Prog. 2019;102(1):3-42. doi: 10.1177\/0036850419826802","journal-title":"Sci Prog"},{"key":"key20260601163209_B13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.envint.2014.12.006","article-title":"Endocrine disrupting chemicals in the atmosphere: their effects on humans and wildlife","volume":"76","author":"Annamalai","year":"2015","unstructured":"13 Annamalai J, Namasivayam V. Endocrine disrupting chemicals in the atmosphere: their effects on humans and wildlife. Environ Int. 2015;76:78-97. doi: 10.1016\/j.envint.2014.12.006","journal-title":"Environ Int"},{"issue":"1","key":"key20260601163209_B14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11154-019-09521-z","article-title":"Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention","volume":"21","author":"Yilmaz","year":"2020","unstructured":"14 Yilmaz B, Terekeci H, Sandal S, Kelestimur F. Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention. Rev Endocr Metab Disord. 2020;21(1):127-47. doi: 10.1007\/s11154-019-09521-z","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"key20260601163209_B15","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1530\/JOE-17-0023","article-title":"Exposure to endocrine disruptors during adulthood: consequences for female fertility","volume":"233","author":"Rattan","year":"2017","unstructured":"15 Rattan S, Zhou C, Chiang C, Mahalingam S, Brehm E, Flaws JA. Exposure to endocrine disruptors during adulthood: consequences for female fertility. J Endocrinol. 2017;233(3):R109-R129. doi: 10.1530\/JOE-17-0023","journal-title":"J Endocrinol"},{"issue":"3","key":"key20260601163209_B16","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.3390\/ijms24032671","article-title":"Endocrine disruptor chemicals and children's health","volume":"24","author":"Di Pietro","year":"2023","unstructured":"16 Di Pietro G, Forcucci F, Chiarelli F. Endocrine disruptor chemicals and children's health. Int J Mol Sci. 2023;24(3):2671. doi: 10.3390\/ijms24032671","journal-title":"Int J Mol Sci"},{"key":"key20260601163209_B17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fendo.2019.00112","article-title":"Endocrine disrupting chemicals: an occult mediator of metabolic disease","volume":"10","author":"Papalou","year":"2019","unstructured":"17 Papalou O, Kandaraki EA, Papadakis G, Diamanti-Kandarakis E. Endocrine disrupting chemicals: an occult mediator of metabolic disease. Front Endocrinol (Lausanne). 2019;10:112. doi: 10.3389\/fendo.2019.00112","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"key20260601163209_B18","first-page":"428","article-title":"Principales disruptores endocrinos vinculados con salud reproductiva femenina: bases biol\u00f3gicas de su asociaci\u00f3n","volume":"82","author":"Marconetto","year":"2022","unstructured":"18 Marconetto A, Babini A, \u00d1a\u00f1ez M, Moreno L, Rosato O, Fux Otta C. Principales disruptores endocrinos vinculados con salud reproductiva femenina: bases biol\u00f3gicas de su asociaci\u00f3n. Medicina (B Aires). 2022;82(3):428-38.","journal-title":"Medicina (B Aires)"},{"key":"key20260601163209_B19","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","unstructured":"19 Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"key20260601163209_B20","doi-asserted-by":"crossref","DOI":"10.46658\/JBIMES-24-01","volume-title":"JBI Manual for Evidence Synthesis","author":"Aromataris","year":"2024","unstructured":"20 Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, editors. JBI Manual for Evidence Synthesis. Adelaide: JBI; 2024 [cited 2024 Dec 15]. Available from: https:\/\/synthesismanual.jbi.global"},{"issue":"1","key":"key20260601163209_B21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","unstructured":"21 Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. doi: 10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"issue":"3","key":"key20260601163209_B22","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2265.2012.04500.x","article-title":"Bisphenol A in polycystic ovary syndrome and its association with liver\u2013spleen axis","volume":"78","author":"Tarantino","year":"2013","unstructured":"22 Tarantino G, Valentino R, Di Somma C, D\u2019Esposito V, Passaretti F, Pizza G, et al. Bisphenol A in polycystic ovary syndrome and its association with liver\u2013spleen axis. Clin Endocrinol (Oxf). 2013;78(3):447-53. doi: 10.1111\/j.1365-2265.2012.04500.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"key20260601163209_B23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1472-6823-14-86","article-title":"Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol a in polycystic ovary syndrome: a case-control study","volume":"14","author":"Vagi","year":"2014","unstructured":"23 Vagi SJ, Azziz-Baumgartner E, Sj\u00f6din A, Calafat AM, Dumesic D, Gonzalez L, et al. Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol a in polycystic ovary syndrome: a case-control study. BMC Endocr Disord. 2014;14(1):86. doi: 10.1186\/1472-6823-14-86","journal-title":"BMC Endocr Disord"},{"issue":"4","key":"key20260601163209_B24","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1111\/apa.12885","article-title":"The endocrine disruptor bisphenol A may play a role in the aetiopathogenesis of polycystic ovary syndrome in adolescent girls","volume":"104","author":"Ak\u0131n","year":"2015","unstructured":"24 Ak\u0131n L, Kendirci M, Narin F, Kurtoglu S, Saraymen R, Kondolot M, et al. The endocrine disruptor bisphenol A may play a role in the aetiopathogenesis of polycystic ovary syndrome in adolescent girls. Acta Paediatr. 2015;104(4):e171-7. doi: 10.1111\/apa.12885","journal-title":"Acta Paediatr"},{"issue":"23","key":"key20260601163209_B25","doi-asserted-by":"crossref","first-page":"23546","DOI":"10.1007\/s11356-016-7573-5","article-title":"Metabolic and endocrine effects of bisphenol A exposure in market seller women with polycystic ovary syndrome","volume":"23","author":"Vahedi","year":"2016","unstructured":"25 Vahedi M, Saeedi A, Poorbaghi SL, Sepehrimanesh M, Fattahi M. Metabolic and endocrine effects of bisphenol A exposure in market seller women with polycystic ovary syndrome. Environ Sci Pollut Res. 2016;23(23):23546-50. doi: 10.1007\/s11356-016-7573-5","journal-title":"Environ Sci Pollut Res"},{"issue":"1","key":"key20260601163209_B26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/ijerph14010018","article-title":"Bisphenol A and ovarian reserve among infertile women with polycystic ovarian syndrome","volume":"14","author":"Zhou","year":"2016","unstructured":"26 Zhou W, Fang F, Zhu W, Chen ZJ, Du Y, Zhang J. Bisphenol A and ovarian reserve among infertile women with polycystic ovarian syndrome. Int J Environ Res Public Health. 2016;14(1):18. doi: 10.3390\/ijerph14010018","journal-title":"Int J Environ Res Public Health"},{"issue":"12","key":"key20260601163209_B27","first-page":"759","article-title":"The association between Bisphenol A and polycystic ovarian syndrome: a case-control study","volume":"55","author":"Hossein Rashidi","year":"2017","unstructured":"27 Hossein Rashidi B, Amanlou M, Behrouzi Lak T, Ghazizadeh M, Haghollahi F, Bagheri M, et al. The association between Bisphenol A and polycystic ovarian syndrome: a case-control study. Acta Med Iran. 2017;55(12):759-64.","journal-title":"Acta Med Iran"},{"issue":"12","key":"key20260601163209_B28","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1177\/0300060519876467","article-title":"The effects of di(2-ethylhexyl) phthalate exposure in women with polycystic ovary syndrome undergoing in vitro fertilization","volume":"47","author":"Jin","year":"2019","unstructured":"28 Jin Y, Zhang Q, Pan JX, Wang FF, Qu F. The effects of di(2-ethylhexyl) phthalate exposure in women with polycystic ovary syndrome undergoing in vitro fertilization. J Int Med Res. 2019;47(12):6278-93. doi: 10.1177\/0300060519876467","journal-title":"J Int Med Res"},{"issue":"10","key":"key20260601163209_B29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019707","article-title":"Environmental exposure to triclosan and polycystic ovary syndrome: a cross-sectional study in China","volume":"8","author":"Ye","year":"2018","unstructured":"29 Ye J, Zhu W, Liu H, Mao Y, Jin F, Zhang J. Environmental exposure to triclosan and polycystic ovary syndrome: a cross-sectional study in China. BMJ Open. 2018;8(10):e019707. doi: 10.1136\/bmjopen-2017-019707","journal-title":"BMJ Open"},{"key":"key20260601163209_B30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.reprotox.2018.09.006","article-title":"Serum bisphenol A concentrations correlate with serum testosterone levels in women with polycystic ovary syndrome","volume":"82","author":"Konieczna","year":"2018","unstructured":"30 Konieczna A, Racho\u0144 D, Owczarek K, Kubica P, Kowalewska A, Kud\u0142ak B, et al. Serum bisphenol A concentrations correlate with serum testosterone levels in women with polycystic ovary syndrome. Reprod Toxicol. 2018;82:32-7. doi: 10.1016\/j.reprotox.2018.09.006","journal-title":"Reprod Toxicol"},{"key":"key20260601163209_B31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.envres.2018.09.014","article-title":"Urinary concentration of personal care products and polycystic ovary syndrome: a case-control study","volume":"168","author":"Gu","year":"2019","unstructured":"31 Gu J, Yuan T, Ni N, Ma Y, Shen Z, Yu X, et al. Urinary concentration of personal care products and polycystic ovary syndrome: a case-control study. Environ Res. 2019;168:48-53. doi: 10.1016\/j.envres.2018.09.014","journal-title":"Environ Res"},{"issue":"12","key":"key20260601163209_B32","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1080\/09513590.2019.1630608","article-title":"Bisphenol A and phthalate levels in adolescents with polycystic ovary syndrome","volume":"35","author":"Akg\u00fcl","year":"2019","unstructured":"32 Akg\u00fcl S, Sur \u00dc, D\u00fcz\u00e7eker Y, Balc\u0131 A, K\u0131z\u0131lkan MP, Kanbur N, et al. Bisphenol A and phthalate levels in adolescents with polycystic ovary syndrome. Gynecol Endocrinol. 2019;35(12):1084-7. doi: 10.1080\/09513590.2019.1630608","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"key20260601163209_B33","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4274\/jcrpe.galenos.2020.2020.0037","article-title":"Endocrine disruptors and polycystic ovary syndrome: phthalates","volume":"12","author":"Ak\u0131n","year":"2020","unstructured":"33 Ak\u0131n L, Kendirci M, Narin F, Kurtoglu S, Hatipo\u011flu N, Elmal\u0131 F. Endocrine disruptors and polycystic ovary syndrome: phthalates. J Clin Res Pediatr Endocrinol. 2020;12(4):393-400. doi: 10.4274\/jcrpe.galenos.2020.2020.0037","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"Suppl 2","key":"key20260601163209_B34","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.33549\/physiolres.934521","article-title":"Endocrine disruptors, obesity, and cytokines - how relevant are they to PCOS?","volume":"69","author":"\u0160imkov\u00e1","year":"2020","unstructured":"34 \u0160imkov\u00e1 M, V\u00edtk\u016f J, Kol\u00e1torov\u00e1 L, Vrb\u00edkov\u00e1 J, Vos\u00e1tkov\u00e1 M, V\u010del\u00e1k J, et al. Endocrine disruptors, obesity, and cytokines - how relevant are they to PCOS? Physiol Res. 2020;69(Suppl 2):S279-93. doi: 10.33549\/physiolres.934521","journal-title":"Physiol Res"},{"issue":"1","key":"key20260601163209_B35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12940-021-00749-4","article-title":"Associations between blood cadmium and endocrine features related to PCOS-phenotypes in healthy women of reproductive age: a prospective cohort study","volume":"20","author":"Kim","year":"2021","unstructured":"35 Kim K, Pollack AZ, Nobles CJ, Sjaarda LA, Zolton JR, Radoc JG, et al. Associations between blood cadmium and endocrine features related to PCOS-phenotypes in healthy women of reproductive age: a prospective cohort study. Environ Health. 2021;20(1):64. doi: 10.1186\/s12940-021-00749-4","journal-title":"Environ Health"},{"issue":"3","key":"key20260601163209_B36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1515\/hmbci-2020-0032","article-title":"Urinary bisphenol A in women with polycystic ovary syndrome \u2013 a possible suppressive effect on steroidogenesis?","volume":"42","author":"Laz\u00farov\u00e1","year":"2021","unstructured":"36 Laz\u00farov\u00e1 Z, Figurov\u00e1 J, Hubkov\u00e1 B, Ma\u0161lankov\u00e1 J, Laz\u00farov\u00e1 I. Urinary bisphenol A in women with polycystic ovary syndrome \u2013 a possible suppressive effect on steroidogenesis? Horm Mol Biol Clin Investig. 2021;14;42(3):303-9. doi: 10.1515\/hmbci-2020-0032","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"Pt 1","key":"key20260601163209_B37","doi-asserted-by":"crossref","first-page":"131495","DOI":"10.1016\/j.chemosphere.2021.131495","article-title":"The relationship between urinary phthalate metabolites and polycystic ovary syndrome in women undergoing in vitro fertilization: nested case-control study","volume":"286","author":"Al-Saleh","year":"2022","unstructured":"37 Al-Saleh I. The relationship between urinary phthalate metabolites and polycystic ovary syndrome in women undergoing in vitro fertilization: nested case-control study. Chemosphere. 2022;286(Pt 1):131495. doi: 10.1016\/j.chemosphere.2021.131495","journal-title":"Chemosphere"},{"key":"key20260601163209_B38","doi-asserted-by":"crossref","first-page":"104233","DOI":"10.1016\/j.etap.2023.104233","article-title":"Individual and joint associations of urinary phthalate metabolites with polycystic ovary and polycystic ovary syndrome: results from the TREE cohort","volume":"102","author":"Zhang","year":"2023","unstructured":"38 Zhang M, Liu C, Yuan XQ, Cui FP, Miao Y, Yao W, et al. Individual and joint associations of urinary phthalate metabolites with polycystic ovary and polycystic ovary syndrome: results from the TREE cohort. Environ Toxicol Pharmacol. 2023;102:104233. doi: 10.1016\/j.etap.2023.104233","journal-title":"Environ Toxicol Pharmacol"},{"key":"key20260601163209_B39","doi-asserted-by":"crossref","first-page":"108511","DOI":"10.1016\/j.reprotox.2023.108511","article-title":"Bisphenol A analogues and metabolic syndrome in women with polycystic ovary syndrome","volume":"123","author":"Majewska","year":"2024","unstructured":"39 Majewska J, Berg A, Jurewicz J, Owczarek K, Zajdel R, Kilanowicz A, et al. Bisphenol A analogues and metabolic syndrome in women with polycystic ovary syndrome. Reprod Toxicol. 2024;123:108511. doi: 10.1016\/j.reprotox.2023.108511","journal-title":"Reprod Toxicol"},{"issue":"5","key":"key20260601163209_B40","doi-asserted-by":"crossref","first-page":"57001","DOI":"10.1289\/EHP11814","article-title":"Environmental exposure to emerging alternatives of per- and polyfluoroalkyl substances and polycystic ovarian syndrome in women diagnosed with infertility: a mixture analysis","volume":"131","author":"Zhan","year":"2023","unstructured":"40 Zhan W, Qiu W, Ao Y, Zhou W, Sun Y, Zhao H, et al. Environmental exposure to emerging alternatives of per- and polyfluoroalkyl substances and polycystic ovarian syndrome in women diagnosed with infertility: a mixture analysis. Environ Health Perspect. 2023;131(5):57001. doi: 10.1289\/EHP11814","journal-title":"Environ Health Perspect"},{"key":"key20260601163209_B41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.chemosphere.2016.12.127","article-title":"Association of serum organochlorine pesticides concentrations with reproductive hormone levels and polycystic ovary syndrome in a Chinese population","volume":"171","author":"Guo","year":"2017","unstructured":"41 Guo Z, Qiu H, Wang L, Wang L, Wang C, Chen M, et al. Association of serum organochlorine pesticides concentrations with reproductive hormone levels and polycystic ovary syndrome in a Chinese population. Chemosphere. 2017;171:595-600. doi: 10.1016\/j.chemosphere.2016.12.127","journal-title":"Chemosphere"},{"key":"key20260601163209_B42","doi-asserted-by":"crossref","first-page":"157780","DOI":"10.1016\/j.scitotenv.2022.157780","article-title":"Exposure to multiple toxic metals and polycystic ovary syndrome risk: endocrine disrupting effect from As, Pb and Ba","volume":"849","author":"Liang","year":"2022","unstructured":"42 Liang C, Zhang Z, Cao Y, Wang J, Shen L, Jiang T, et al. Exposure to multiple toxic metals and polycystic ovary syndrome risk: endocrine disrupting effect from As, Pb and Ba. Sci Total Environ. 2022;849:157780. doi: 10.1016\/j.scitotenv.2022.157780","journal-title":"Sci Total Environ"},{"key":"key20260601163209_B43","doi-asserted-by":"crossref","first-page":"120786","DOI":"10.1016\/j.envres.2025.120786","article-title":"Associations of maternal per- and polyfluoroalkyl substance plasma concentrations during pregnancy with offspring polycystic ovary syndrome and related characteristics in project viva","volume":"268","author":"Wang","year":"2025","unstructured":"43 Wang Z, Fleisch A, Rifas-Shiman SL, Calafat AM, James-Todd T, Coull BA, et al. Associations of maternal per- and polyfluoroalkyl substance plasma concentrations during pregnancy with offspring polycystic ovary syndrome and related characteristics in project viva. Environ Res. 2025;268:120786. doi: 10.1016\/j.envres.2025.120786","journal-title":"Environ Res"},{"key":"key20260601163209_B44","doi-asserted-by":"crossref","first-page":"100090","DOI":"10.1016\/j.obmed.2019.100090","article-title":"Bisphenol A (BPA) acts as an endocrine disruptor in women with Polycystic Ovary Syndrome: hormonal and metabolic evaluation","volume":"14","author":"Kawa","year":"2019","unstructured":"44 Kawa IA, Masood A, Ganie MA, Fatima Q, Jeelani H, Manzoor S, et al. Bisphenol A (BPA) acts as an endocrine disruptor in women with Polycystic Ovary Syndrome: hormonal and metabolic evaluation. Obes Med. 2019;14:100090. doi: 10.1016\/j.obmed.2019.100090","journal-title":"Obes Med"},{"key":"key20260601163209_B45","doi-asserted-by":"crossref","first-page":"108562","DOI":"10.1016\/j.reprotox.2024.108562","article-title":"Endocrine-disrupting chemicals and hormonal profiles in PCOS women: a comparative study between urban and rural environment","volume":"125","author":"Patel","year":"2024","unstructured":"45 Patel J, Chaudhary H, Panchal S, Joshi T, Joshi R. Endocrine-disrupting chemicals and hormonal profiles in PCOS women: a comparative study between urban and rural environment. Reprod Toxicol. 2024;125:108562. doi: 10.1016\/j.reprotox.2024.108562","journal-title":"Reprod Toxicol"},{"key":"key20260601163209_B46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cca.2020.05.009","article-title":"Can environmental pollutant bisphenol A increase metabolic risk in polycystic ovary syndrome?","volume":"507","author":"Milanovi\u0107","year":"2020","unstructured":"46 Milanovi\u0107 M, Milo\u0161evi\u0107 N, Sudji J, Stojanoski S, Atanackovi\u0107 Krstono\u0161i\u0107 M, Bjelica A, et al. Can environmental pollutant bisphenol A increase metabolic risk in polycystic ovary syndrome? Clin Chim Acta. 2020;507:257-63. doi: 10.1016\/j.cca.2020.05.009","journal-title":"Clin Chim Acta"},{"key":"key20260601163209_B47","doi-asserted-by":"crossref","first-page":"117225","DOI":"10.1016\/j.cca.2023.117225","article-title":"The effects of phthalate exposure on metabolic parameters in polycystic ovary syndrome","volume":"540","author":"Milankov","year":"2023","unstructured":"47 Milankov A, Milanovi\u0107 M, Milo\u0161evi\u0107 N, Sudji J, Pejakovi\u0107 S, Mili\u0107 N, et al. The effects of phthalate exposure on metabolic parameters in polycystic ovary syndrome. Clin Chim Acta. 2023;540:117225. doi: 10.1016\/j.cca.2023.117225","journal-title":"Clin Chim Acta"},{"key":"key20260601163209_B48","doi-asserted-by":"crossref","first-page":"115962","DOI":"10.1016\/j.envpol.2020.115962","article-title":"Serum bisphenol A analogues in women diagnosed with the polycystic ovary syndrome \u2013 is there an association?","volume":"272","author":"Jurewicz","year":"2021","unstructured":"48 Jurewicz J, Majewska J, Berg A, Owczarek K, Zajdel R, Kaleta D, et al. Serum bisphenol A analogues in women diagnosed with the polycystic ovary syndrome \u2013 is there an association? Environ Pollut. 2021;272:115962. doi: 10.1016\/j.envpol.2020.115962","journal-title":"Environ Pollut"},{"key":"key20260601163209_B49","doi-asserted-by":"crossref","first-page":"104738","DOI":"10.1016\/j.etap.2025.104738","article-title":"Exposure to airborne polychlorinated biphenyls and risk of uterine leiomyomata, endometriosis, and polycystic ovarian syndrome: a register-based Danish cohort study","volume":"117","author":"T\u00f8ttenborg","year":"2025","unstructured":"49 T\u00f8ttenborg SS, Wise LA, Wesselink AK, Nielsen HS, Petersen KU, Fox MP, et al. Exposure to airborne polychlorinated biphenyls and risk of uterine leiomyomata, endometriosis, and polycystic ovarian syndrome: a register-based Danish cohort study. Environ Toxicol Pharmacol. 2025;117:104738. doi: 10.1016\/j.etap.2025.104738","journal-title":"Environ Toxicol Pharmacol"},{"key":"key20260601163209_B50","doi-asserted-by":"crossref","first-page":"106819","DOI":"10.1016\/j.envint.2021.106819","article-title":"Perfluoroalkyl substances (PFAS) in drinking water and risk for polycystic ovarian syndrome, uterine leiomyoma, and endometriosis: a Swedish cohort study","volume":"157","author":"Hammarstrand","year":"2021","unstructured":"50 Hammarstrand S, Jakobsson K, Andersson E, Xu Y, Li Y, Olovsson M, et al. Perfluoroalkyl substances (PFAS) in drinking water and risk for polycystic ovarian syndrome, uterine leiomyoma, and endometriosis: a Swedish cohort study. Environ Int. 2021;157:106819. doi: 10.1016\/j.envint.2021.106819","journal-title":"Environ Int"},{"key":"key20260601163209_B51","doi-asserted-by":"crossref","first-page":"1233484","DOI":"10.3389\/fendo.2023.1233484","article-title":"Serum polychlorinated biphenyl levels and circulating miRNAs in non-obese women with and without polycystic ovary syndrome","volume":"14","author":"Brennan","year":"2023","unstructured":"51 Brennan E, Butler AE, Drage DS, Sathyapalan T, Atkin SL. Serum polychlorinated biphenyl levels and circulating miRNAs in non-obese women with and without polycystic ovary syndrome. Front Endocrinol (Lausanne). 2023;14:1233484. doi: 10.3389\/fendo.2023.1233484","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"23","key":"key20260601163209_B52","doi-asserted-by":"crossref","first-page":"64025","DOI":"10.1007\/s11356-023-26820-w","article-title":"Distinct metabolic signatures in blood plasma of bisphenol A\u2013exposed women with polycystic ovarian syndrome","volume":"30","author":"Prabhu","year":"2023","unstructured":"52 Prabhu NB, Vasishta S, Bhat SK, Joshi MB, Kabekkodu SP, Satyamoorthy K, et al. Distinct metabolic signatures in blood plasma of bisphenol A\u2013exposed women with polycystic ovarian syndrome. Environ Sci Pollut Res. 2023;30(23):64025-35. doi: 10.1007\/s11356-023-26820-w","journal-title":"Environ Sci Pollut Res"},{"issue":"2","key":"key20260601163209_B53","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1515\/reveh-2019-0034","article-title":"A review on sources and health impacts of bisphenol A","volume":"35","author":"Abraham","year":"2019","unstructured":"53 Abraham A, Chakraborty P. A review on sources and health impacts of bisphenol A. Rev Environ Health. 2019;35(2):201-10. doi: 10.1515\/reveh-2019-0034","journal-title":"Rev Environ Health"},{"key":"key20260601163209_B54","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.etap.2016.09.014","article-title":"Bisphenol A and its analogs: do their metabolites have endocrine activity?","volume":"47","author":"Gramec Skledar","year":"2016","unstructured":"54 Gramec Skledar D, Peterlin Ma\u0161i\u010d L. Bisphenol A and its analogs: do their metabolites have endocrine activity? Environ Toxicol Pharmacol. 2016;47:182-99. doi: 10.1016\/j.etap.2016.09.014","journal-title":"Environ Toxicol Pharmacol"},{"issue":"4","key":"key20260601163209_B55","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1515\/reveh-2020-0032","article-title":"Bisphenol-A and polycystic ovary syndrome: a review of the literature","volume":"35","author":"Kechagias","year":"2020","unstructured":"55 Kechagias KS, Semertzidou A, Athanasiou A, Paraskevaidi M, Kyrgiou M. Bisphenol-A and polycystic ovary syndrome: a review of the literature. Rev Environ Health. 2020;35(4):323-31. doi: 10.1515\/reveh-2020-0032","journal-title":"Rev Environ Health"},{"issue":"45","key":"key20260601163209_B56","doi-asserted-by":"crossref","first-page":"52","DOI":"10.52428\/20756208.v18i45.1000","article-title":"Revisi\u00f3n sistem\u00e1tica: el t\u00f3xico silencioso de la vida moderna bisfenol A","volume":"18","author":"Calvo Gutierrez","year":"2023","unstructured":"56 Calvo Gutierrez H. Revisi\u00f3n sistem\u00e1tica: el t\u00f3xico silencioso de la vida moderna bisfenol A. Rev Invest Inform Salud. 2023;18(45):52-67. doi: 10.52428\/20756208.v18i45.1000","journal-title":"Rev Invest Inform Salud"},{"issue":"23","key":"key20260601163209_B57","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.3390\/jcm11237227","article-title":"Bisphenol-A and female fertility: an update of existing epidemiological studies","volume":"11","author":"Stavridis","year":"2022","unstructured":"57 Stavridis K, Triantafyllidou O, Pisimisi M, Vlahos N. Bisphenol-A and female fertility: an update of existing epidemiological studies. J Clin Med. 2022;11(23):7227. doi: 10.3390\/jcm11237227","journal-title":"J Clin Med"},{"issue":"18","key":"key20260601163209_B58","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.3390\/ijerph17186811","article-title":"Effects and mechanisms of phthalates\u2019 action on reproductive processes and reproductive health: a literature review","volume":"17","author":"Hlisn\u00edkov\u00e1","year":"2020","unstructured":"58 Hlisn\u00edkov\u00e1 H, Petrovi\u010dov\u00e1 I, Kolena B, \u0160idlovsk\u00e1 M, Sirotkin A. Effects and mechanisms of phthalates\u2019 action on reproductive processes and reproductive health: a literature review. Int J Environ Res Public Health. 2020;17(18):6811. doi: 10.3390\/ijerph17186811","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"key20260601163209_B59","first-page":"1057","article-title":"Determination of serum levels of three phthalate esters in patients with polycystic ovary syndrome","volume":"6","author":"Xu","year":"2011","unstructured":"59 Xu C, Lin H, Zhao Y, Zhang Y. Determination of serum levels of three phthalate esters in patients with polycystic ovary syndrome. Sci Res Essays. 2011;6(5):1057-62. doi: 10.5897\/SRE10.918","journal-title":"Sci Res Essays"},{"key":"key20260601163209_B60","doi-asserted-by":"crossref","first-page":"1324993","DOI":"10.3389\/fendo.2023.1324993","article-title":"The adverse role of endocrine disrupting chemicals in the reproductive system","volume":"14","author":"Pan","year":"2024","unstructured":"60 Pan J, Liu P, Yu X, Zhang Z, Liu J. The adverse role of endocrine disrupting chemicals in the reproductive system. Front Endocrinol (Lausanne). 2024;14:1324993. doi: 10.3389\/fendo.2023.1324993","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"key20260601163209_B61","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/09513590.2018.1534951","article-title":"Serum levels of phthalates and bisphenol-A in patients with primary ovarian insufficiency","volume":"35","author":"\u00d6zel","year":"2019","unstructured":"61 \u00d6zel \u015e, Tokmak A, Aykut O, Aktulay A, Han\u00e7erlio\u011fullar\u0131 N, Engin Ustun Y. Serum levels of phthalates and bisphenol-A in patients with primary ovarian insufficiency. Gynecol Endocrinol. 2019;35(4):364-7. doi: 10.1080\/09513590.2018.1534951","journal-title":"Gynecol Endocrinol"},{"issue":"8","key":"key20260601163209_B62","first-page":"533","article-title":"Etiological role of environmental toxicants in polycystic ovarian syndrome","volume":"6","author":"Rozati","year":"2019","unstructured":"62 Rozati R, Fatima S. Etiological role of environmental toxicants in polycystic ovarian syndrome. Int J Res Rev. 2019;6(8):533-44.","journal-title":"Int J Res Rev"},{"issue":"1","key":"key20260601163209_B63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12011-015-0294-7","article-title":"Association of serum heavy metals and trace element concentrations with reproductive hormone levels and polycystic ovary syndrome in a Chinese population","volume":"167","author":"Zheng","year":"2015","unstructured":"63 Zheng G, Wang L, Guo Z, Sun L, Wang L, Wang C, et al. Association of serum heavy metals and trace element concentrations with reproductive hormone levels and polycystic ovary syndrome in a Chinese population. Biol Trace Elem Res. 2015;167(1):1-10. doi: 10.1007\/s12011-015-0294-7","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"key20260601163209_B64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/187152206775528941","article-title":"Cadmium as an endocrine disruptor in the reproductive system","volume":"6","author":"Chedrese","year":"2006","unstructured":"64 Chedrese PJ, Piasek M, Henson MC. Cadmium as an endocrine disruptor in the reproductive system. Immunol Endocr Metab Agents Med Chem. 2006;6(1):27-35. doi: 10.2174\/187152206775528941","journal-title":"Immunol Endocr Metab Agents Med Chem"},{"issue":"1","key":"key20260601163209_B65","first-page":"33","article-title":"Impact of triclosan on female and male reproductive system and its consequences on fertility: a literature review","volume":"6","author":"Maksymowicz","year":"2022","unstructured":"65 Maksymowicz M, R\u0119ka G, Machowiec P, Piecewicz-Szcz\u0119sna H. Impact of triclosan on female and male reproductive system and its consequences on fertility: a literature review. J Family Reprod Health. 2022;6(1):33-42. doi: 10.18502\/jfrh.v16i1.8592","journal-title":"J Family Reprod Health"},{"key":"key20260601163209_B66","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.reprotox.2019.07.086","article-title":"Triclosan exposure and ovarian reserve","volume":"89","author":"Jurewicz","year":"2019","unstructured":"66 Jurewicz J, Wielgomas B, Radwan M, Karwacka A, Klimowska A, Dziewirska E, et al. Triclosan exposure and ovarian reserve. Reprod Toxicol. 2019;89:168-72. doi: 10.1016\/j.reprotox.2019.07.086","journal-title":"Reprod Toxicol"},{"key":"key20260601163209_B67","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.chemosphere.2016.06.037","article-title":"Assessment of multiple hormone activities of a UV-filter (octocrylene) in zebrafish (Danio rerio)","volume":"159","author":"Zhang","year":"2016","unstructured":"67 Zhang QY, Ma XY, Wang XC, Ngo HH. Assessment of multiple hormone activities of a UV-filter (octocrylene) in zebrafish (Danio rerio). Chemosphere. 2016;159:433-41. doi: 10.1016\/j.chemosphere.2016.06.037","journal-title":"Chemosphere"},{"issue":"5","key":"key20260601163209_B68","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/humupd\/dmaa018","article-title":"Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary","volume":"26","author":"Ding","year":"2020","unstructured":"68 Ding N, Harlow SD, Randolph JF Jr, Loch-Caruso R, Park SK. Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary. Hum Reprod Update. 2020;26(5):724-52. doi: 10.1093\/humupd\/dmaa018","journal-title":"Hum Reprod Update"},{"key":"key20260601163209_B69","doi-asserted-by":"crossref","first-page":"153031","DOI":"10.1016\/j.tox.2021.153031","article-title":"Per- and poly-fluoroalkyl substances (PFAS) and female reproductive outcomes: PFAS elimination, endocrine-mediated effects, and disease","volume":"465","author":"Rickard","year":"2022","unstructured":"69 Rickard BP, Rizvi I, Fenton SE. Per- and poly-fluoroalkyl substances (PFAS) and female reproductive outcomes: PFAS elimination, endocrine-mediated effects, and disease. Toxicology. 2022;465:153031. doi: 10.1016\/j.tox.2021.153031","journal-title":"Toxicology"},{"issue":"4","key":"key20260601163209_B70","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.3390\/ijms22042148","article-title":"Endocrine disruptor potential of short- and long-chain perfluoroalkyl substances (PFASs)-a synthesis of current knowledge with proposal of molecular mechanism","volume":"22","author":"Mokra","year":"2021","unstructured":"70 Mokra K. Endocrine disruptor potential of short- and long-chain perfluoroalkyl substances (PFASs)-a synthesis of current knowledge with proposal of molecular mechanism. Int J Mol Sci. 2021;22(4):2148. doi: 10.3390\/ijms22042148","journal-title":"Int J Mol Sci"},{"issue":"1","key":"key20260601163209_B71","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/life13010138","article-title":"Polycystic ovary syndrome and endocrine disruptors (Bisphenols, Parabens, and Triclosan)-a systematic review","volume":"13","author":"Srnovr\u0161nik","year":"2023","unstructured":"71 Srnovr\u0161nik T, Virant-Klun I, Pinter B. Polycystic ovary syndrome and endocrine disruptors (Bisphenols, Parabens, and Triclosan)-a systematic review. Life. 2023;13(1):138. doi: 10.3390\/life13010138","journal-title":"Life"},{"key":"key20260601163209_B72","doi-asserted-by":"crossref","first-page":"828532","DOI":"10.1155\/2013\/828532","article-title":"Endocrine-disrupting chemicals: some actions of POPs on female reproduction","volume":"2013","author":"Gregoraszczuk","year":"2013","unstructured":"72 Gregoraszczuk EL, Ptak A. Endocrine-disrupting chemicals: some actions of POPs on female reproduction. Int J Endocrinol. 2013;2013:828532. doi: 10.1155\/2013\/828532","journal-title":"Int J Endocrinol"},{"issue":"5","key":"key20260601163209_B73","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/09513590.2017.1405931","article-title":"The association between the environmental endocrine disruptor bisphenol A and polycystic ovary syndrome: a systematic review and meta-analysis","volume":"34","author":"Hu","year":"2018","unstructured":"73 Hu Y, Wen S, Yuan D, Peng L, Zeng R, Yang Z, et al. The association between the environmental endocrine disruptor bisphenol A and polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol. 2018;34(5):370-7. doi: 10.1080\/09513590.2017.1405931","journal-title":"Gynecol Endocrinol"},{"key":"key20260601163209_B74","doi-asserted-by":"crossref","first-page":"108473","DOI":"10.1016\/j.reprotox.2023.108473","article-title":"Phthalates and polycystic ovary syndrome \u2013 Systematic literature review","volume":"121","author":"Neuvonen","year":"2023","unstructured":"74 Neuvonen R, Huovinen M, Dorman DC, Laitinen H, Sahlman H. Phthalates and polycystic ovary syndrome \u2013 Systematic literature review. Reprod Toxicol. 2023;121:108473. doi: 10.1016\/j.reprotox.2023.108473","journal-title":"Reprod Toxicol"},{"issue":"2","key":"key20260601163209_B75","doi-asserted-by":"crossref","first-page":"e2023015","DOI":"10.5620\/eaht.2023015","article-title":"Association of triclosan and human infertility: a systematic review","volume":"38","author":"Daza-Rodr\u00edguez","year":"2023","unstructured":"75 Daza-Rodr\u00edguez B, Aparicio-Marenco D, M\u00e1rquez-L\u00e1zaro J. Association of triclosan and human infertility: a systematic review. Environ Anal Health Toxicol. 2023;38(2):e2023015-0. doi: 10.5620\/eaht.2023015","journal-title":"Environ Anal Health Toxicol"}],"container-title":["Revista Brasileira de Ginecologia e Obstetr\u00edcia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:32:24Z","timestamp":1780331544000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalrbgo.org\/article\/association-between-exposure-to-endocrine-disrupting-chemicals-and-polycystic-ovary-syndrome-a-systematic-review-a-systematic-review\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":75,"alternative-id":["10.61622\/rbgo\/2026rbgo19"],"URL":"https:\/\/doi.org\/10.61622\/rbgo\/2026rbgo19","relation":{},"ISSN":["0100-7203","1806-9339"],"issn-type":[{"value":"0100-7203","type":"print"},{"value":"1806-9339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e-rbgo19"}}